1. Home
  2. HSHP vs DRTS Comparison

HSHP vs DRTS Comparison

Compare HSHP & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSHP
  • DRTS
  • Stock Information
  • Founded
  • HSHP 2021
  • DRTS 2015
  • Country
  • HSHP Bermuda
  • DRTS Israel
  • Employees
  • HSHP N/A
  • DRTS N/A
  • Industry
  • HSHP
  • DRTS Medical/Dental Instruments
  • Sector
  • HSHP
  • DRTS Health Care
  • Exchange
  • HSHP Nasdaq
  • DRTS Nasdaq
  • Market Cap
  • HSHP 268.6M
  • DRTS 300.2M
  • IPO Year
  • HSHP 2023
  • DRTS N/A
  • Fundamental
  • Price
  • HSHP $8.71
  • DRTS $3.86
  • Analyst Decision
  • HSHP
  • DRTS Strong Buy
  • Analyst Count
  • HSHP 0
  • DRTS 1
  • Target Price
  • HSHP N/A
  • DRTS $9.00
  • AVG Volume (30 Days)
  • HSHP 122.7K
  • DRTS 63.3K
  • Earning Date
  • HSHP 08-08-2025
  • DRTS 08-11-2025
  • Dividend Yield
  • HSHP 5.15%
  • DRTS N/A
  • EPS Growth
  • HSHP N/A
  • DRTS N/A
  • EPS
  • HSHP 0.14
  • DRTS N/A
  • Revenue
  • HSHP $120,680,000.00
  • DRTS N/A
  • Revenue This Year
  • HSHP $7.10
  • DRTS N/A
  • Revenue Next Year
  • HSHP $26.34
  • DRTS N/A
  • P/E Ratio
  • HSHP $62.71
  • DRTS N/A
  • Revenue Growth
  • HSHP 44.77
  • DRTS N/A
  • 52 Week Low
  • HSHP $4.29
  • DRTS $2.11
  • 52 Week High
  • HSHP $8.87
  • DRTS $4.39
  • Technical
  • Relative Strength Index (RSI)
  • HSHP 78.03
  • DRTS 53.89
  • Support Level
  • HSHP $8.08
  • DRTS N/A
  • Resistance Level
  • HSHP $8.44
  • DRTS $3.99
  • Average True Range (ATR)
  • HSHP 0.14
  • DRTS 0.16
  • MACD
  • HSHP 0.06
  • DRTS -0.11
  • Stochastic Oscillator
  • HSHP 91.73
  • DRTS 96.74

About HSHP Himalaya Shipping Ltd.

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: